Champions Oncology, Inc. (CSBR) - Cash Funds Calculated per Share

Champions Oncology Corp - graphic logo of issuer CSBR

A regular cash inflow from pharmaceutical orders provides Champions Oncology (CSBR) with financial stability. Cash per share trends visualize current liquidity, where the parameter value reaches 0.31. Margin growth is based on the utilization of accumulated data sets, while the recruitment of top specialists is guaranteed by scientific freedom and stock option programs, strengthening the company's technological potential.

CSBR Champions Oncology, Inc.: Cash Funds per Share in the range 07/04/2022 - 11/21/2026

Analytical breakdowns for championsoncology.com (CSBR)

- stock price and consensus target price:
Comprehensive company analysis:CSBR (Champions Oncology Inc)
Manufactured product of Champions Oncology

Cash per share determines the level of immediate business liquidity per security. The cash per share trend is calculated by dividing the total balance of cash and cash equivalents by the number of shares outstanding. This metric allows for an assessment of the company's financial stability and internal reserves. For Champions Oncology (CSBR), this capital supports the development of a unique live tumor database. Such resources are critical for scaling predictive tests to serve pharmaceutical behemoths.

Analysis of competing companies

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash on Hand per Share Y-mAbs Therapeutics Inc YMAB|Cash per Share AURA|CADL (Candel Therapeutics, Inc.) - Amount of Cash per Share|Cash Funds per Share Accuray Inc ARAY|Cash Funds Calculated per Share SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Cash per Share|Cash on Hand per Share Citius Oncology|HURA: Cash per Share|Cash Money per Share TARA (Protara)|FATE (fatetherapeutics.com) - Cash per Share|Cash on Hand per Share Aadi Bioscience WHWK|Cash per Share TCRX|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com